Inside Precision Medicine August 6, 2025
By Helen Albert

A cornerstone of precision medicine, pharmacogenomic testing allows drug treatment for a disease to be tailored to a person’s genetic makeup. Despite a large amount of research having been carried out in this area from the 1990s onward, only a few of the findings have reached the clinic in the form of tests.

High costs, unreliable data, and a lack of physician education have been cited as reasons for this slow adoption, but recent developments like improvements in data and guidelines, reductions in test costs, and government support for pharmacogenomics suggest that the this technology will be increasingly adopted in the U.S. and elsewhere in the near future.

Drug-metabolizing enzymes evolved to help humans and other animals metabolize poisonous substances...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Pharma / Biotech, Precision Medicine
JPM 2026: Genoa Ventures’ Jenny Rooke on Next-Gen Clinical Assessment Tools
From Early Detection to Targeted Therapy: How AI is Reframing Precision Medicine
How Precision Medicine and AI are Evolving: An MD Anderson Perspective
Bringing Precision Medicine Into the Home
Inside the Virtual Cell: New Depths for Precision Medicine

Share Article